Last reviewed · How we verify
THC-Medium Dose
At a glance
| Generic name | THC-Medium Dose |
|---|---|
| Sponsor | Deepak C. D'Souza |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study Testing the Effects of Different THC Doses on Psychological and Biological Function (PHASE1)
- Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration (PHASE2)
- Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability (PHASE2)
- Acute Effects of THC in Older Adult (PHASE1)
- Cannabis Edibles and Simulated Driving (NA)
- Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans (PHASE1)
- Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease (PHASE2)
- Study of the Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Humans (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- THC-Medium Dose CI brief — competitive landscape report
- THC-Medium Dose updates RSS · CI watch RSS
- Deepak C. D'Souza portfolio CI